Illinois Tool Works Inc. vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Illinois Tool Works Inc. trades at $262.71 (market cap $74.38B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.69 (market cap $25.27B). The key difference: Illinois Tool Works Inc. is far larger — about 2.9× Royalty Pharma plc Class A Ordinary Shares's market cap, and Illinois Tool Works Inc. pays the higher dividend (2.63%). Which is the better fit depends on your goals — on Pluang, investors hold Illinois Tool Works Inc. for 67 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.
| ITW | RPRX | |
|---|---|---|
Market Cap | $74.38B | $25.27B |
Volume | 1,125,477 | 3,671,183 |
Sector | Industrials | Health |
52-Week High | $299.60 | $63.96 |
52-Week Low | $241.07 | $35.44 |
Typical Hold Time | 67 Days | 0 Days |
Enterprise Value | $83.23B | $32.50B |
Dividend Yield | 2.63% | 1.66% |
Signals from Pluang's Aura AI — not financial advice
ITW trades at $261.15, down 2.24% on the day, with technical indicators showing bearish momentum as the stock tests support near $261. The company maintains strong fundamentals with a 19.39% net income margin and has beaten earnings estimates for three consecutive quarters. Recent news highlights ITW's dividend increase to $1.72 per share, reinforcing its status as a Dividend King with 59 years of consecutive increases.
The outlook remains mixed with solid profitability offset by bearish technicals. Upside potential exists toward the $276.86 analyst consensus target, but investors face headwinds from weak technical momentum and mixed analyst sentiment where only 21% recommend buying. Key risks include debt levels rising to 55.54% of assets and exposure to cyclical industrial demand.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Illinois Tool Works is a diversified global manufacturer that produces specialized industrial equipment, consumables, and related services. The firm operates 87 global divisions through seven distinct operating segments: automotive OEM, construction products, food equipment, specialty products, test/measurement and electronics, polymers and fluids, and welding. About half of its revenue comes from its operations in North America, with the remainder originating from international markets. ITW takes a bottom-up and decentralized approach to portfolio management, with the exception that each segment must apply its 80/20 operating process modeled on the Pareto principle.
Read more on ITW →Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →